Published in N Y State J Med on January 01, 1981
Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA (1996) 4.10
Suppressing unwanted memories by executive control. Nature (2001) 3.59
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
Constitutive activation of toll-mediated antifungal defense in serpin-deficient Drosophila. Science (1999) 2.95
Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ (2011) 2.74
A review of the use of health status measures in economic evaluation. Health Technol Assess (1999) 2.62
An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess (2007) 2.46
Follow-up families who experience a perinatal death. Pediatrics (1978) 2.22
Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J (2000) 2.15
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry (2006) 2.06
Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.00
The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev (1999) 1.98
Plasma membranes: phospholipid and sterol content. Science (1966) 1.87
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess (2010) 1.80
Leginon: a system for fully automated acquisition of 1000 electron micrographs a day. Ultramicroscopy (1999) 1.75
Molecular basis of the action of interferon. J Mol Biol (1968) 1.70
Evidence-based practice: extending the search to find material for the systematic review. Bull Med Libr Assoc (2001) 1.66
The incorporation of steroid molecules into lecithin sols, beta-lipoproteins and cellular membranes. Eur J Biochem (1968) 1.61
The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess (2011) 1.59
AIDS-related discrimination in Asia. AIDS Care (2005) 1.58
A novel method for constructing an alternative spacer for patients with asthma. S Afr Med J (1999) 1.54
Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium. J Invest Dermatol (1997) 1.52
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J (1996) 1.52
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia (2008) 1.50
The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health Technol Assess (2003) 1.47
Spatial correlates of firing patterns of single cells in the subiculum of the freely moving rat. J Neurosci (1994) 1.45
Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med (1972) 1.44
Ribosomes: effect of interferon on their interaction with rapidly labeled cellular and viral RNA's. Science (1967) 1.44
The recognition of viral RNA by mammalian ribosomes. An effect of interferon. Biochim Biophys Acta (1968) 1.44
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer (2009) 1.43
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Inhibition of biologic activity of poly I: poly C by human plasma. Proc Soc Exp Biol Med (1970) 1.42
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess (2004) 1.42
Another cause for bradycardia during neurosurgery. Anaesthesia (1990) 1.41
Demonstration of epidermal transfer from a polymer membrane using genetically marked porcine keratinocytes. Burns (2001) 1.40
Pharmaceutical donations to eastern Europe. BMJ (1995) 1.40
Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery (1996) 1.39
Functional outcome after restorative panproctocolectomy for ulcerative colitis decreases an otherwise enhanced quality of life. Br J Surg (2000) 1.39
Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res (2000) 1.39
Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine. J Infect Dis (1977) 1.33
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
Reassociation rate limited displacement of DNA strands by branch migration. Nucleic Acids Res (1981) 1.32
The incidence and size of gap junctions between the bone cells in rat calvaria. Anat Embryol (Berl) (1993) 1.32
Properties of aqueous dispersions of phospholipid and cholesterol. Eur J Biochem (1968) 1.32
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess (2006) 1.30
Effect of interferon on early interferon production. Science (1966) 1.30
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial. Aliment Pharmacol Ther (2005) 1.29
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 1.26
Use of a bilingual medical history questionnaire in the emergency department. Ann Emerg Med (1993) 1.25
Targeted deletions of sequences from closed circular DNA. Proc Natl Acad Sci U S A (1980) 1.22
HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression. J Acquir Immune Defic Syndr (2003) 1.20
Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation (1996) 1.20
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
An interdisciplinary method of classifying and monitoring medication errors. Am J Hosp Pharm (1985) 1.19
The effect of polyinosinic-polycytidylic acid upon graft-vs-host activity in BALB/c mice. J Immunol (1970) 1.18
Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol (2012) 1.18
Biomarkers for smoking cessation. Clin Pharmacol Ther (2013) 1.15
Interferon and uninfected cells. Proc Soc Exp Biol Med (1966) 1.15
The entry of palmitic acid into rat-liver cells. Biochem J (1967) 1.14
Germline transmission of exogenous genes in the chicken. Science (1989) 1.14
The identification of specific Rhesus-polypeptide-blood-group-ABH-active-glycoprotein complexes in the human red-cell membrane. Biochem J (1987) 1.11
A review of the use of health status measures in economic evaluation. J Health Serv Res Policy (1999) 1.11
A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes. Vox Sang (1990) 1.11
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Lancet (1976) 1.10
Interferon: lack of detectable uptake by cells. Science (1966) 1.09
Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. Infect Immun (1976) 1.09
Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J Biol Chem (2001) 1.08
Interferon and interferon inducers in the treatment of malignancies. Arch Intern Med (1970) 1.08
The uptake of lipids by rat liver cells. Biochem J (1966) 1.07
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys. J Infect Dis (1979) 1.07
Complications of modified Blalock-Taussig shunts mimicking pulmonary disease. Arch Dis Child (1998) 1.06
The exchange of unesterified cholesterol between human low-density lipoproteins and rat erythrocyte 'ghosts'. Biochem J (1967) 1.06
A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int (2002) 1.06
Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun (1979) 1.05
Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob Agents Chemother (1995) 1.04
Issues concerning parents after the death of their newborn. Crit Care Med (1980) 1.04
Experimental model of anorectal transplantation. Br J Surg (2000) 1.03
Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science (1977) 1.03
The isolation of rat liver plasma membrane fragments. Biochim Biophys Acta (1968) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Lack of correlation between interferon induction and antitumour effect of poly I-poly C. Nat New Biol (1971) 1.02
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex. Antimicrob Agents Chemother (1977) 1.01
Discrimination between ricin and sulphur mustard toxicity in vitro using Raman spectroscopy. J R Soc Interface (2004) 1.01
GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL. Cytotherapy (2004) 1.01
Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res (1979) 1.01
Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia. J Clin Neurophysiol (2000) 1.00
Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol (1996) 1.00
Phase I-II trials of poly IC stabilized with poly-L-lysine. Cancer Treat Rep (1978) 1.00
A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology (2006) 1.00
The adhesion of different cell types to cultured vascular endothelium: effects of culture density and age. Br J Exp Pathol (1984) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
Postinfectious encephalopathy after treatment of herpes simplex encephalitis with acyclovir. Pediatr Infect Dis (1984) 0.99
Similarity and inhibition in long-term memory: evidence for a two-factor theory. J Exp Psychol Learn Mem Cogn (2000) 0.98
Using the person trade-off approach to examine differences between individual and social values. Health Econ (1998) 0.97
The effect of interferon, interferon inducers or interferon induced virus resistance on subsequent interferon production. J Gen Virol (1972) 0.97
MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol (1995) 0.96
Induction of interferon in lymphoblastoid cell lines. Proc Soc Exp Biol Med (1970) 0.96
Users' perceptions of a computerised information system in intensive care (ABICUS) on introduction and after 2 months use. Int J Clin Monit Comput (1991) 0.96